Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Cysteine-rich secretory protein 3 inhibits hepatitis C virus at the initial phase of infection.

Lee U, Nam YR, Ye JS, Lee KJ, Kim N, Joo CH.

Biochem Biophys Res Commun. 2014 Jul 25;450(2):1076-82. doi: 10.1016/j.bbrc.2014.06.106. Epub 2014 Jun 27.

PMID:
24978310
2.

Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.

Guévin C, Lamarre A, Labonté P.

Antiviral Res. 2009 Oct;84(1):14-22. doi: 10.1016/j.antiviral.2009.07.009. Epub 2009 Jul 19.

PMID:
19622372
3.

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

Frentzen A, Anggakusuma, Gürlevik E, Hueging K, Knocke S, Ginkel C, Brown RJ, Heim M, Dill MT, Kröger A, Kalinke U, Kaderali L, Kuehnel F, Pietschmann T.

Hepatology. 2014 Jan;59(1):78-88. doi: 10.1002/hep.26626. Epub 2013 Nov 18.

PMID:
23873628
4.

Human immunodeficiency virus enhances hepatitis C virus replication by differential regulation of IFN and TGF family genes.

Zhang X, Daucher M, Baeza J, Kim CW, Russell R, Kottilil S.

J Med Virol. 2012 Sep;84(9):1344-52. doi: 10.1002/jmv.23315.

PMID:
22825812
5.

Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation.

Koutsoudakis G, Perez-del-Pulgar S, Coto-Llerena M, Gonzalez P, Dragun J, Mensa L, Crespo G, Navasa M, Forns X.

PLoS One. 2011;6(8):e23587. doi: 10.1371/journal.pone.0023587. Epub 2011 Aug 24.

6.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
7.

Hepatitis C virus is restricted at both entry and replication in mouse hepatocytes.

Park IW, Ndjomou J, Fan Y, Henao-Mejia J, He JJ.

Biochem Biophys Res Commun. 2009 Sep 25;387(3):489-93. doi: 10.1016/j.bbrc.2009.07.076. Epub 2009 Jul 18.

PMID:
19619513
8.

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

Helle F, Brochot E, Fournier C, Descamps V, Izquierdo L, Hoffmann TW, Morel V, Herpe YE, Bengrine A, Belouzard S, Wychowski C, Dubuisson J, Francois C, Regimbeau JM, Castelain S, Duverlie G.

PLoS One. 2013 Aug 5;8(8):e70809. doi: 10.1371/journal.pone.0070809. Print 2013.

9.

The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.

Hoffmann TW, Delfosse F, Helle F, François C, Duverlie G, Castelain S.

Arch Virol. 2014 Mar;159(3):527-34. doi: 10.1007/s00705-013-1862-9. Epub 2013 Oct 8.

PMID:
24100473
10.

Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.

Dharel N, Kato N, Muroyama R, Taniguchi H, Otsuka M, Wang Y, Jazag A, Shao RX, Chang JH, Adler MK, Kawabe T, Omata M.

Hepatology. 2008 Apr;47(4):1136-49. doi: 10.1002/hep.22176.

PMID:
18220274
11.

Basal replication of hepatitis C virus in nude mice harboring human tumor.

Labonté P, Morin N, Bowlin T, Mounir S.

J Med Virol. 2002 Mar;66(3):312-9.

PMID:
11793382
12.

Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.

Gai X, Zhao P, Pan Y, Shan H, Yue X, Du J, Zhang Z, Liu P, Ma H, Guo M, Yang X, Sun W, Gao L, Ma C, Liang X.

Int J Biochem Cell Biol. 2013 Jul;45(7):1174-85. doi: 10.1016/j.biocel.2013.03.015. Epub 2013 Mar 27.

PMID:
23542016
13.

Permissiveness of human hepatoma cell lines for HCV infection.

Sainz B Jr, Barretto N, Yu X, Corcoran P, Uprichard SL.

Virol J. 2012 Jan 24;9:30. doi: 10.1186/1743-422X-9-30.

14.

CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.

Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R.

Hepatology. 2013 Jan;57(1):23-36. doi: 10.1002/hep.25966.

PMID:
22814930
15.

Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.

Das S, Shetty RK, Kumar A, Shridharan RN, Tatineni R, Chi G, Mukherjee A, Das S, Subbarao SM, Karande AA.

PLoS One. 2013;8(1):e53619. doi: 10.1371/journal.pone.0053619. Epub 2013 Jan 15.

16.

Hepatitis virus infection affects DNA methylation in mice with humanized livers.

Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, Fujii M, Osada H, Sekido Y, Murakami S, Tanaka Y, Joh T, Sato S, Takahashi S, Wakita T, Zhu J, Issa JP, Kondo Y.

Gastroenterology. 2014 Feb;146(2):562-72. doi: 10.1053/j.gastro.2013.10.056. Epub 2013 Oct 30.

PMID:
24184133
17.

Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines.

Murakami K, Kimura T, Osaki M, Ishii K, Miyamura T, Suzuki T, Wakita T, Shoji I.

J Gen Virol. 2008 Jul;89(Pt 7):1587-92. doi: 10.1099/vir.0.83618-0.

PMID:
18559928
18.

Two methods of heterokaryon formation to discover HCV restriction factors.

Frentzen A, Hueging K, Bitzegeio J, Pietschmann T, Steinmann E.

J Vis Exp. 2012 Jul 16;(65):e4029. doi: 10.3791/4029.

19.

CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection.

Liu Y, Zou Z, Zhu B, Hu Z, Zeng P.

Int J Mol Sci. 2013 Dec 13;14(12):24230-41. doi: 10.3390/ijms141224230.

20.

Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.

Tripathi LP, Kambara H, Moriishi K, Morita E, Abe T, Mori Y, Chen YA, Matsuura Y, Mizuguchi K.

J Proteome Res. 2012 Jul 6;11(7):3664-79. doi: 10.1021/pr300121a. Epub 2012 Jun 12.

PMID:
22646850

Supplemental Content

Support Center